终末期肾病(ＥＳＲＤ)引起的肾性贫血最有效的治疗是使用促红细胞生成素(ＥＰＯ)。近有报道,血管紧张素转换酶抑制剂(ＡＣＥＩ)加重透析患者贫血或造成ＥＰＯ抵抗[1],但也有报道未见ＡＣＥＩ影响透析患者的ＥＰＯ疗效[2]。本研究旨在观察ＡＣＥＩ对血透患者ＥＰＯ疗效的影响及 The most effective treatment for renal anemia caused by end-stage renal disease (ESRD) is the use of erythropoietin (EPO). It has been reported recently that angiotensin converting enzyme inhibitors (ACEIs) aggravate anemia or cause EPO resistance in dialysis patients [1]. However, it has also been reported that no ACEI affects EPO in dialysis patients [2]. The purpose of this study was to investigate the effect of ACEI on the efficacy of EPO in hemodialysis patients